WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'9601 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 8'7881 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 45'239  45'530  45'803  46'050  46'267  49'057  51'659  49'974 
Births 490  495  498  498  494  402  672  758 
Surviving infants 485  489  492  492  488  396  660  742 
Pop. less than 5 years 2'532  2'589  2'567  2'423  2'354  2'139  3'637  3'727 
Pop. less than 15 years 6'544  6'523  6'487  6'399  6'457  8'570  11'137  10'771 
Female 15-49 years 11'251  11'446  11'637  11'825  11'950  12'765  12'365  12'776 

Number of reported case

(Click for retrospective incidence data for Ukraine)
Diphtheria 17  365  109 
Japanese encephalitis
Measles 12'746  1'333  39  817  6'841 
Mumps 799  955  951  26'538 
Pertussis 2'286  2'937  1'067  2'243  4'189 
Polio*
Rubella 1'952  3'667  2'333  37'931 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 23  12  13  36 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ukraine)
Vaccine year result method % card seen                                                
BCG 2011  95  MICS   92  95  90  92  99 
DTP1 2011  86  MICS   92  42  46  98 
DTP3 2011  74  MICS   92  76  50  52  99 
HepB_BD          51  53  64 
HepB3          46  21  48 
Hib3          83  26  51 
JapEnc         
MCV 2011  73  MICS   92  79  67  56  99 
MCV2          54  56  41  99 
PCV1         
PCV3         
Pol3 2011  73  MICS   92  74  58  57  99 
Rota1         
Rota_last         
Rubella1          79  56 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ukraine)
BCG 95  95  90  92  94  98 
DTP1 90  76  50  52  71  99 
DTP3 76  76  50  52  71  99 
HepB3 46  46  21  48  66 
HepB_BD 51  51  53  64  73 
Hib3 83  83  26  51  66 
MCV 79  79  67  56  75  99 
MCV2 54  54  56  41  68  99 
PCV3
Pol3 74  74  58  57  74  99 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 7 years; Yes
DT 6 years; Yes
DTwP 3, 4, 5, 18 months; Yes
DTwPHibIPV 3, 4 months; Yes
HepB Birth; 1, 6 months; Yes
HIB 18 months; Yes
MMR 12 months; 6 years; Yes
OPV 5, 18 months; 6, 14 years; Yes
Td 14, 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes  Yes  Yes    No  Yes 
What years does the MYP cover? number   2009-2015  2009-2015  2009-2015      2007-2015 
Nº of districts with microplans that include activities to raise immunization coverage number           490   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR     No  No       

System performance

Total Nº districts in country number           490  490 
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%          
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND     Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR     Yes  Yes    Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%           100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.